Humana adds Medicaid coverage for DataMeds AI cancer test
Alpha Vantage · Benzinga · · AI-summarised by FinFlash
DataMeds AI shares rose after Humana expanded its Medicaid coverage to include the ChemoFx assay for gynecologic cancers, covering CPT Codes 81535 and 81536. The lab-developed test predicts how cancer cells may respond to chemotherapy, with ICERs as low as $2,736 per life-year saved. ChemoFx has not been cleared or approved by the FDA.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.